<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03161821</url>
  </required_header>
  <id_info>
    <org_study_id>LCCC 1121</org_study_id>
    <secondary_id>11-1924</secondary_id>
    <nct_id>NCT03161821</nct_id>
  </id_info>
  <brief_title>Circulating Tumor Cells in Solid Tumors</brief_title>
  <official_title>Quantification and Characterization of Circulating Tumor Cells in Solid Tumors</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>UNC Lineberger Comprehensive Cancer Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>UNC Lineberger Comprehensive Cancer Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to identify circulating tumor cells in patients with solid
      tumors. Quantify and characterize these cells, collect patient information in regards to the
      patient's cancer. Develop a database and a sample repository where future analysis could be
      done.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The primary purpose of this correlative study is to create a prospective database documenting
      the quantity and characterization of circulating tumor cells (CTCs) in solid tumor patients
      as identified by a various laboratory techniques and analyses. The investigators are
      developing this resource to provide data to achieve the following objectives: 1) correlate
      CTCs with known prognostic factors, 2) correlate CTCs with burden of disease, 3) evaluate the
      ability of CTCs to be used in the surveillance of disease recurrence, and 4) evaluate CTCs
      ability to be used as a biomarker for treatment response.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 9, 2011</start_date>
  <completion_date type="Anticipated">December 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 1, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Documentation of the Quality of CTCs from Patients with Solid Tumors</measure>
    <time_frame>Through study completion, an average of 5 years</time_frame>
    <description>Enumeration of participants' circulating solid tumor cells</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Documentation of the Characterization of CTCs from Patients with Solid Tumors</measure>
    <time_frame>Through study completion, an average of 5 years</time_frame>
    <description>Characterization of participants' circulating solid tumor cells</description>
  </primary_outcome>
  <enrollment type="Anticipated">250</enrollment>
  <condition>Solid Tumor, Adult</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Observational</intervention_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with cancerous solid tumors
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age â‰¥ 18 years of age

          -  Biopsy proven solid tumor malignancy

          -  Seen at UNC Chapel Hill Hospital and Health Care System

          -  Consents to abstraction of their medical records

          -  Signed an institutional review board (IRB)-approved informed consent document for this
             protocol

        Exclusion Criteria:

          -  &lt; 18 years of age

          -  Dementia, altered mental status, incarceration or any psychiatric condition that would
             prohibit the understanding or rendering of informed consent.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gaorav P Gupta, MD, MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of North Carolina</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Gaorav P Gupta, MD, MPH</last_name>
    <phone>919-945-4166</phone>
    <email>gaorav_gupta@med.unc.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Radiation Oncology Clinic - UNC Cancer Hospital</name>
      <address>
        <city>Chapel Hill</city>
        <state>North Carolina</state>
        <zip>27599</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>William Y Kim, MD</last_name>
      <email>wykim@med.unc.edu</email>
    </contact>
    <investigator>
      <last_name>Jen Jen Yeh, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nancy Allbritton, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Christopher E Sims, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Autumn McRee, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Joel Tepper, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Bhishamjit S Chera, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://unclineberger.org/patientcare/clinical-trials/clinical-trials</url>
    <description>UNC Lineberger Comprehensive Cancer Center Clinical Trials</description>
  </link>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 15, 2017</study_first_submitted>
  <study_first_submitted_qc>May 18, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 22, 2017</study_first_posted>
  <last_update_submitted>January 2, 2018</last_update_submitted>
  <last_update_submitted_qc>January 2, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 4, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neoplastic Cells, Circulating</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

